OPUSLINE IS NOW PART OF ACCENTURE
Uncategorized - 1 December 2020
We are pleased to inform you that OpusLine and Accenture have finalized the acquisition process announced on October 27th. OpusLine is now officially part of Accenture! In 2012, we created OpusLine with the ambition to leave our mark on the health and life insurance sector. To take up this challenge, we have shed light on the changes underway, driven dynamics…...
[Public] Nouvelle étape pour le Numérique en santé ! Le 31 août, l'Agence du numérique en santé a ouvert son guiche… https://t.co/25ouB4KV3J
[Innovation] What is remote patient monitoring and what does it mean for the future of #healthcare? #RPM enables… https://t.co/1HXMz9nzRJ
[OpusTalks] Lors de ce premier épisode sur l'article 51, @BouetJ et @Ge_Oneill, vous proposent d'écouter Natacha Le… https://t.co/9WJEtC8Bqe
An alternative go-to-market and pricing framework to enable value co-creation between pharmas and payers
Note d’actualité - 6 November 2019
Aware that the actual go-to-market and pricing framework is not anymore sustainable, OpusLine developed a new framework that delivers shared value among payers, patients and pharmaceutical companies. The modelization of this framework has been presented at ISPOR Europe 2019. Background Over the past decade, pharmaceutical companies have faced challenges directly affecting their P&L: 69% Increase in trial duration in…...
The increasing popularity of Real World Data with 186 studies presented at ASCO 2019
Publication - 8 July 2019
186 real-world data studies have been presented at ASCO 2019. These studies highlight the increasing awareness on the value of real world data and real world evidence. Among these studies, 113 studies were on the efficacy, the safety or the quality of life, 74 studies on the patient care and follow-up and 22 studies on medical practice. …...
Results of the study “Industry of the future: challenges and perspectives for the health industry” led by OpusLine
Uncategorized - 4 July 2019
Innovative and positioned across the entire value chain, the drug, in vitro diagnostics and medical device industries are a strategic sector with a considerable economic weight in France. With a growing competitive intensity and a complexification of health product needs, they now need to rethink their positioning and their modes of operation. The integration of industry of the future…...
Health Data Hub: an ambitious French initiative for tomorrow’s health
Publication - 25 March 2019
A strategic tool to serve innovation and promote Artificial Intelligence in healthcare The French Health law project "Ma santé 2022" including the creation of the Health Data Hub and the “Espace Numérique de Santé” (ENS), e-health personal space, has been adopted by the National Assembly on March 16th 2019. It should be under examination by the senate in May. At…...